2m 2m 2m 2m 2m 2m 2m
ACTUATE THERAP (ACTU)
NASDAQ
$1.11-$0.005 (-0.45%)
Price as of Aug 03, 2026 12:41 PM EDT- $26.6MMarket Cap
- -84.71%1-Year Change
- BiotechnologyIndustry
ACTUATE THERAP (ACTU)
$1.11-$0.005 (-0.45%)
ACTU | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.11 | ||
Change | -$0.06 (-5.13%) | ||
Open | $1.19 | ||
High | $1.21 | ||
Low | $1.09 | ||
Previous Close | $1.17 | ||
Volume | 157,074 | ||
30-Day Average Volume | 415,658 | ||
1-Week Change | -5.93% | ||
1-Month Change | -27.45% | ||
1-Year Change | -84.71% | ||
3-Year Change | -77.80% | ||
5-Year Change | -77.80% | ||
Fundamentals | |||
Shares Outstanding | 23.9M | ||
Total Assets | $8.9M | ||
Market Cap | $26.6M | ||
Enterprise Value | $18.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$5.0M | ||
EBIT | $0.00 | ||
EBITDA | $0.00 | ||
Net Working Capital | $3.8M | ||
EPS | -$0.24 | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | 7 | ||
P/E | -5 | ||
PEG | N/A | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue